143 related articles for article (PubMed ID: 10415856)
21. Interleukin 1 alpha and tumor necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells.
Woodworth CD; McMullin E; Iglesias M; Plowman GD
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2840-4. PubMed ID: 7708734
[TBL] [Abstract][Full Text] [Related]
22. The mRNA expression of cytokines and their receptors in cultured iris pigment epithelial cells: a comparison with retinal pigment epithelial cells.
Kociok N; Heppekausen H; Schraermeyer U; Esser P; Thumann G; Grisanti S; Heimann K
Exp Eye Res; 1998 Aug; 67(2):237-50. PubMed ID: 9733590
[TBL] [Abstract][Full Text] [Related]
23. Growth factors in bladder cancer.
Liebert M
World J Urol; 1995; 13(6):349-55. PubMed ID: 9116754
[TBL] [Abstract][Full Text] [Related]
24. Growth factor receptors: structure, mechanism, and drug discovery.
McInnes C; Sykes BD
Biopolymers; 1997; 43(5):339-66. PubMed ID: 9566117
[TBL] [Abstract][Full Text] [Related]
25. The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.
Kleeff J; Ishiwata T; Kumbasar A; Friess H; Büchler MW; Lander AD; Korc M
J Clin Invest; 1998 Nov; 102(9):1662-73. PubMed ID: 9802880
[TBL] [Abstract][Full Text] [Related]
26. Chronic exposure of transforming growth factor beta 1 confers a more aggressive tumor phenotype through downregulation of p21(WAF1/CIP1) in conditionally immortalized pancreatic epithelial cells.
Ito D; Fujimoto K; Doi R; Koizumi M; Toyoda E; Mori T; Kami K; Kawaguchi Y; Whitehead R; Imamura M
Surgery; 2004 Aug; 136(2):364-74. PubMed ID: 15300203
[TBL] [Abstract][Full Text] [Related]
27. TGFbeta1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation.
Giehl K; Seidel B; Gierschik P; Adler G; Menke A
Oncogene; 2000 Sep; 19(39):4531-41. PubMed ID: 11002426
[TBL] [Abstract][Full Text] [Related]
28. Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways.
Haarmann-Stemmann T; Bothe H; Abel J
Biochem Pharmacol; 2009 Feb; 77(4):508-20. PubMed ID: 18848820
[TBL] [Abstract][Full Text] [Related]
29. Fetal growth factors as determinants of intrauterine hepatic growth.
Gruppuso PA; Curran TR; Mead JE; Fausto N; Oh W
Diabetes; 1991 Dec; 40 Suppl 2():51-5. PubMed ID: 1660827
[TBL] [Abstract][Full Text] [Related]
30. Cytokines in human melanoma cells: synthesis, autocrine stimulation and regulatory functions--an overview.
Krasagakis K; Garbe C; Orfanos CE
Melanoma Res; 1993 Dec; 3(6):425-33. PubMed ID: 8161882
[TBL] [Abstract][Full Text] [Related]
31. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma.
Löhr M; Schmidt C; Ringel J; Kluth M; Müller P; Nizze H; Jesnowski R
Cancer Res; 2001 Jan; 61(2):550-5. PubMed ID: 11212248
[TBL] [Abstract][Full Text] [Related]
33. [Role of polypeptide growth factors in the regulation of epidermal keratinocyte proliferation].
Gusak VK; Vasil'ev RG; Zubov DA; Slipchenko IO; Korchak OM; Popandopulo AG
Tsitol Genet; 2001; 35(6):64-73. PubMed ID: 11944330
[TBL] [Abstract][Full Text] [Related]
34. Induction of interleukin-8 (CXCL-8) by tumor necrosis factor-alpha and leukemia inhibitory factor in pancreatic carcinoma cells: Impact of CXCL-8 as an autocrine growth factor.
Kamohara H; Takahashi M; Ishiko T; Ogawa M; Baba H
Int J Oncol; 2007 Sep; 31(3):627-32. PubMed ID: 17671691
[TBL] [Abstract][Full Text] [Related]
35. Role of growth factors and their receptors in gastric ulcer healing.
Milani S; Calabrò A
Microsc Res Tech; 2001 Jun; 53(5):360-71. PubMed ID: 11376497
[TBL] [Abstract][Full Text] [Related]
36. Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells.
Villanueva A; García C; Paules AB; Vicente M; Megías M; Reyes G; de Villalonga P; Agell N; Lluís F; Bachs O; Capellá G
Oncogene; 1998 Oct; 17(15):1969-78. PubMed ID: 9788440
[TBL] [Abstract][Full Text] [Related]
37. Bone morphogenetic proteins and growth and differentiation factors in the human cornea.
You L; Kruse FE; Pohl J; Völcker HE
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):296-311. PubMed ID: 9950587
[TBL] [Abstract][Full Text] [Related]
38. Human colon cancer cell lines secrete alpha TGF-like activity.
Hanauske AR; Buchok J; Scheithauer W; Von Hoff DD
Br J Cancer; 1987 Jan; 55(1):57-9. PubMed ID: 3493023
[No Abstract] [Full Text] [Related]
39. [New molecular targets in pancreatic cancer].
Torrisani J; Bournet B; Cordelier P; Buscail L
Bull Cancer; 2008 May; 95(5):503-12. PubMed ID: 18541514
[TBL] [Abstract][Full Text] [Related]
40. Cytokine-mediated enhancement of epidermal growth factor receptor expression provides an immunological approach to the therapy of pancreatic cancer.
Schmiegel W; Schmielau J; Henne-Bruns D; Juhl H; Roeder C; Buggisch P; Onur A; Kremer B; Kalthoff H; Jensen EV
Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12622-6. PubMed ID: 9356499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
